flu vaccine 結果共12筆

Stay informed about the latest updates on flu and COVID-19 vaccination in Taiwan. With flu vaccine supplies running low, the Taiwan CDC urges residents to get vaccinated. Learn more about vaccination locations and second doses for high-risk individuals.

Stay informed about Taiwan’s government-funded influenza vaccination program starting on March 5. All citizens aged six months and older are now eligible for flu shots to curb the spread of the flu post-lantern festivals. High-risk groups like seniors, preschool children, and medical staff are encouraged to get vaccinated promptly. Supplies are limited, with about 70,000 doses left as of Feb. 27. Vaccine effectiveness varies by age and health condition, ranging from 30 to 80 percent.

Taiwan’s CDC announces government-funded flu vaccines will be available starting March 5 for those unvaccinated for over six months, amidst a surge of over 112,486 reported cases in a week. With stocks dwindling to 70,000 doses, eligible individuals urged to seek early inoculation.

This year’s flu season during the Lunar New Year has been relatively mild, potentially due to higher flu vaccination rates and continued mask-wearing, according to Philip Lo, the Deputy Director-General and spokesperson for the Centers for Disease Control (CDC). Typically, flu cases surge before and after the Lunar New Year, with the second day of the new year being the busiest for emergency rooms. Despite higher numbers in recent years, this year’s figures are considered mild compared to the pre-pandemic period. On the second day of the Lunar New Year, 6,787 individuals sought emergency care for flu-like symptoms. In previous years, the corresponding numbers were 4,313 in 2023, 1,564 in 2022, 2,458 in 2021, 9,240 in 2020, and 7,983 in 2019. Lo emphasized the need to monitor the potential impact of large gatherings as schools reopen and the travel season begins. In terms of vaccine stock, there are still 82,000 doses of the flu vaccine available, along with 226,000 doses of the Novavax COVID-19 vaccine and 4.38 million doses of the Moderna COVID-19 vaccine. Lo urged eligible individuals to get vaccinated promptly to enhance their protection.

Taiwan has received 462,800 doses of Novavax’s XBB vaccine, with distribution starting on January 9, 2023, according to the Taiwan Centers for Diseases Control (CDC). In May of this year, Taiwan categorized Covid-19 as a class 4 endemic disease, similar to seasonal flu. The decision was based on clinical trial reports and immunization recommendations from the U.S., the European Union (EU), and the Advisory Committee on Immunization Practices (ACIP) of the Ministry of Health and Welfare (MOHW). Unvaccinated individuals are advised to receive two doses of 0.5mL each, administered at least four weeks apart. Those who have already received a COVID-19 vaccine should receive a single dose of 0.5mL, provided at least three months have passed since their last dose. The domestically available XBB vaccine includes those produced by Moderna and Novavax, and recipients can choose either brand for vaccination.

Taiwan’s Centers for Disease Control (CDC) warns of a potential flu epidemic around the Lunar New Year due to an increase in Type B influenza infections. Over 6 million government-funded flu vaccines have been administered, with a vaccination rate exceeding 50% among senior citizens. Several counties have reached the target vaccination rate of 55% for seniors. Influenza outpatient and emergency department visits have shown a recent downward trend, but adenoviruses remain the leading respiratory pathogens. H3N2 is more prevalent than H1N1, with a rising proportion of Type B influenza cases. There have been 14 new severe influenza complications and three additional deaths, mainly affecting individuals with chronic illnesses who were unvaccinated. As of December 11, 6.098 million public-funded flu vaccine doses have been administered, achieving a vaccination rate of 50.4%. Officials urge eligible citizens to promptly get vaccinated, as approximately 500,000 doses of government-funded flu vaccine remain.

Physicians are urging the public to get vaccinated against the flu as cold and flu cases surge in Taiwan amid cooling weather. Even healthcare providers are being impacted by the rapid spread of a virulent seasonal virus. ENT Dr. Chang Yi-Hao fell ill with gastroenteritis in late October, experiencing two days of fever. The virus has been particularly aggressive over the past few months. Chang emphasized the importance of vaccination, especially for the elderly, individuals with chronic diseases, and young children with weaker immune systems. Wearing face masks has become routine due to COVID-19, but with the easing of restrictions, there has been a rise in flu and respiratory virus infections. Physicians stress the need for vaccination, particularly for those with lower resistance to disease.

Eight new regulations are taking effect in Taiwan in November, covering sectors in healthcare, public transport, and the environment. The Taiwan High Speed Rail (THSR) is introducing sustainable deals, offering a NT$5 discount on hot beverages to passengers who bring their own reusable cups. State-funded flu vaccines will be available for individuals aged 50 to 64, and those aged 65 and over can take shots in the second phase of the pneumococcal vaccine program.

Deputy Minister of Health and Welfare, Wang Pi-sheng, criticizes the ban of certain flu vaccine brands in schools, calling it a political move that exploits students. The government has approved a new flu vaccine from Medigen, but rumors of public resistance have led some regions to prohibit its use in schools. Wang argues that the government should help citizens make informed decisions based on scientific evidence.

Taichung Mayor Lu Shiow-yen emphasized transparency in flu vaccine information during the Municipal Administrative Meeting. The central government has purchased publicly-funded flu vaccines from four companies: Sanofi, Adimmune, TTY Biopharm, and Medigen. These vaccines will be available across all cities and counties.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.

Taiwan prioritizes 65+ for Moderna vaccine, offers test kits and vouchers. Hospitals see a 30% increase in patients. Doctors urge prompt antiviral medication for flu. Elderly advised to get COVID and flu vaccines, with pneumococcal vaccine later.